Treatment

Cisplatinum Accord clinical trials

1 indexed studies · 0 currently recruiting

Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Randomized, Double Blind, Phase 3 Study of Platinum-Based Chemotherapy With or Without INCMGA00012 in First-Line Metastatic Squamous and Nonsquamous Non–Small Cell Lung Cancer (POD1UM-304)
This study looks at a new drug, retifanlimab, alongside standard chemotherapy for advanced lung cancer. It aims to see if adding retifanlimab helps people live longer and if it's safe. It's for adults with specific types of non-small cell lung cancer that has spread.
For: Metastatic nonsquamous or squamous non-small cell lung cancer
Czechia · Bulgaria